CKD care should prioritize prevention and kidney health maintenance, as CKD is expected to be a leading cause of death by ...

Mepolizumab reduced COPD exacerbations in patients with eosinophilic inflammation, highlighting the potential of ...

Martin Dietrich, MD, PhD, a medical oncologist at the Cancer Care Centers of Brevard and an assistant professor at the ...

The study suggests that adding a Bruton tyrosine kinase inhibitor (BTKi) to frontline chemoimmunotherapy in Richter ...

Oral roflumilast showed potential as a nonbiologic systemic therapy for moderate to severe psoriasis, offering an alternative ...

Here are the top 5 articles and videos on NHL for 2025: ...

Readers of AJMC gravitated to articles on technology, policy, and clinical workflows, reflecting the pursuit of improved ...

The San Antonio Breast Cancer Symposium fosters collaboration among experts, enhancing research and treatment strategies for breast cancer's complex landscape.

The FDA has approved the subcutaneous administration of a fixed combination of amivantamab (Rybrevant; Johnson & Johnson) and a recombinant human hyaluronidase for patients with non–small cell lung ...

Breast cancer in young women is driven by more aggressive molecular and epidemiologic features and requires age-specific, multidisciplinary management that balances oncologic goals with fertility ...

Today, Takeda announced positive topline results from 2 pivotal phase 3 trials of zasocitinib (TAK-279; Takeda), demonstrating superiority over placebo across key efficacy end points in adults with ...

Increased BMI and IBD have causal effects on the risk of hidradenitis suppurativa, as shown by Mendelian randomization ...